{"id":6319,"date":"2021-09-09T15:42:20","date_gmt":"2021-09-09T15:42:20","guid":{"rendered":"https:\/\/www.adacyte.com\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/"},"modified":"2024-02-07T03:40:45","modified_gmt":"2024-02-07T02:40:45","slug":"pediatric-patient-does-the-ideal-target-in-uc-treatment-exist","status":"publish","type":"educational-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/","title":{"rendered":"Pediatric patient: Does the ideal target in UC treatment exist?"},"content":{"rendered":"<div class=\"wp-block-image is-style-default\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png\" alt=\"\" class=\"wp-image-6236\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong><em>Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes.<\/em><\/strong><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>The benefits of using steroids, immunosuppressants or biologics need to be carefully weighed against the risks: effects of the treatments on growth and development, bone health, and psychosocial functioning. Taken together, novel therapeutic approaches that will demonstrate adequate efficacy combined with acceptable safety profiles are continually needed.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>This high-level medical e-learning course with Spanish leading experts in Immunology and IBD management will discuss if it is possible a promise of better and safer long-term outcomes compared with current approaches and which could be the role of Adacolumn in this special population.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><\/p>\n<\/div>","protected":false},"template":"","educational-corner-categories":[732],"class_list":["post-6319","educational-corner","type-educational-corner","status-publish","hentry","educational-corner-categories-e-learning-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes. The benefits of using steroids, immunosuppressants or biologics need to be carefully [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-07T02:40:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/\",\"url\":\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/\",\"name\":\"Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png\",\"datePublished\":\"2021-09-09T15:42:20+00:00\",\"dateModified\":\"2024-02-07T02:40:45+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/","og_locale":"es_ES","og_type":"article","og_title":"Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte","og_description":"Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes. The benefits of using steroids, immunosuppressants or biologics need to be carefully [&hellip;]","og_url":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/","og_site_name":"Adacyte","article_modified_time":"2024-02-07T02:40:45+00:00","og_image":[{"url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/","url":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/","name":"Pediatric patient: Does the ideal target in UC treatment exist? - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage"},"image":{"@id":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png","datePublished":"2021-09-09T15:42:20+00:00","dateModified":"2024-02-07T02:40:45+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/es\/professional\/educational-corner\/pediatric-patient-does-the-ideal-target-in-uc-treatment-exist\/#primaryimage","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/09\/pediatric-patient-webinar-image-web-1-e1683805023171.png"},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/educational-corner\/6319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/educational-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/educational-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=6319"}],"wp:term":[{"taxonomy":"educational-corner-categories","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/educational-corner-categories?post=6319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}